Recruiting NA Liver Metastases

New treatment option for Liver Metastases

Official title TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery

ClinicalTrials.gov ID: NCT06050200

What this study is testing

What it's testing
Liver resection is the treatment of choice in patients with malignant liver lesions. Unfortunately, the surgery is not always an option, as in same patients the future remnant liver (FRL) is too small to supply all the functions.
  • Time commitment: about 6 years
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 80

You may be able to join if

  • age \>= 18 years
  • patients qualified for liver resection
  • future remnant liver \<30% of standard liver volume
  • written informed consent

You likely can't join if

  • liver cirrhosis
  • pregnancy
  • poor general health status or comorbidities excluding general anesthesia or hepatic resection
  • contraindications to iodine contrast agents

The study team makes the final eligibility decision.

Where it's taking place

  • Warsaw, Masovian Voivodeship, Poland

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 6 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Warsaw, Masovian Voivodeship, Poland. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.